FDA to Expand Its Authority Over Stem-Cell Treatment Facilities – Wall Street Journal (subscription)
Wall Street Journal (subscription) |
FDA to Expand Its Authority Over Stem–Cell Treatment Facilities
Wall Street Journal (subscription) The Food and Drug Administration is stepping up oversight of fledgling medical treatments that aim to harness the potential of stem cells—as well as some businesses that the agency said were selling unapproved and possibly harmful treatments. The FDA … |
